Photo by rawpixel on Unsplash
Photo by rawpixel on Unsplash

When Interest Rates Rise: Winners and Losers

Video Transcript, Youtube
Transcribed by Glenford S. Robinson
Narrated by the Wall Street Journal

The Federal Reserve is ready for lift off. After holding its federal funds rate near zero for 7 years, the US Central bank has signal, it will begin gradually raising interest rates citing the strengthening of the economy. So, who wins and who loses when rates rise? Let’s start with the winners. Banks have been yearning for the Feds to raise rates to stem the decline in their net interest margin, an important measure of bank’s profitability.
The interest rates banks charge on many loans are directly tied to the Fed’s target rate; so, they will immediately earn more interest on those items; thereby, boosting the banks bottom line.

Higher rates will also strengthen the US dollar, but there is also growing consensus that the dollar’s biggest gains may already be in the rearview mirror. The green back has appreciated over 20% against other currencies since July 2014 in anticipation of a rate hike. A strong dollar is a positive for consumers buying goods or traveling overseas, but the flipside is that a strong dollar ends up hurting American exporters.

Life insurers have been the biggest cheerleaders for a sustain rise in interest rates. Most insurers earn substantial income from investing premiums, and they typically favor high quality bonds whose yields have plummeted in recent years amid extended low interest rate conditions.

Now, for some losers in an environment of higher rates; a rising dollar in the wake of a rate hike, could way on oil prices by making dollar-traded oil, more expensive for buyers using foreign currencies. It also would hurt US oil producers by making oil production more expensive in the US and for companies using local weaker currencies, and gold is expected to struggle once the US central bank hikes rates, as the precious metal doesn’t pay interest and cost money to hold. Thereby, making it less appealing than other heavens like treasury bonds.

Rate-sensitive stocks such as consumer staples, telecom, and utilities are those with high dividend yields. These companies have been popular with investors over the past few years for generating steady income. But with rising rates, bond yields are poised to become more attractive to investors looking for relatively stable places to park their money, and here is a draw when it comes to higher rates: In general, higher mortgage rates hurt home affordability as potential buyer cannot spend as much on a home to get the same monthly payment. But contrary to that logic, a hike in short-term interest rates doesn’t spell trouble for the housing market, at least not yet. Short-term rates have an indirect relationship to mortgage cost, which are still near historically low levels. The Fed is expected to hike rates gradually and in small increments and that could potentially spur prospective buyers to lock-in a home loan now instead of later.

Source:

Wall Street Journal
Published on Dec 16, 2015

WSJ rounds up who stands to benefit and lose the most whenever the Federal Reserve decides to raise interest rates.
Subscribe to the WSJ channel here: http://bit.ly/14Q81Xy
More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter: https://twitter.com/WSJvideo
Follow WSJ on Instagram: http://instagram.com/wsj
Follow WSJ on Pinterest: http://www.pinterest.com/wsj/
Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy
More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com
Visit the WSJ Video Center: https://wsj.com/video
On Facebook: https://www.facebook.com/pg/wsj/videos/
On Twitter: https://twitter.com/WSJ
On Snapchat: https://on.wsj.com/2ratjSM

Check Also

Bitcoin at All-Time Lows: Time to Buy, Says Bitcoin Experts…

Bitcoin will mint new millionaires in 2019

What About the New 52-Week High Mark for a Stock?

For the short-term minded trader who elects to buy the stock as a result of its 52-week outstanding performance, short-term trouble could be on the horizon. The main reason why there could be trouble is because professional and institutional traders use a stock’s 52-week high mark has a take-profit point where they lock in their gains accrued over the past year.

Meridian Bioscience, Inc., Stock (VIVO) in Spot Light Today After FDA Granted Marketing Authorization of Alethia CMV Assay Test System to the Company

According to the Centers for Disease Control and Prevention, more than half of adults by age 40 have been infected with CMV. Most people infected with CMV show no signs or symptoms of infection. However, CMV infection can cause serious health problems for people with weakened immune systems and for some newborns.

Fastest Way to Make Short-Term Profits in the Stock Market is Shorting Stocks

My discovery explains the reason why most traders lose money in the stock market. Those losing traders just approach the market the wrong way. First, one must understand that what goes up must come down to some degree because profit has to be made by traders. However, what goes down doesn’t necessarily mean that it will come back up at all. That is because companies do run out of business, which cause their stock prices to plummet without recovery.

SEC Settles Insider Trading Claims Against Former Chairman and CEO of Advanced Medical Optics

The SEC's complaint alleged that in October 2008 Mazzo executed a nondisclosure agreement with Abbott Laboratories, Inc., as Abbott explored a potential acquisition of AMO...

Pfizer Stock (PFE) on Investor Radar Today, Nov 23, 2018, After FDA Approval of Its Acute Myeloid Leukemia Drug Daurismo (glasdegib)

The FDA granted the approval of Daurismo to Pfizer...

Restore Bio Inc., Stock (TORC) Up Over 6% On Positive FDA Phase 2b Trial News for RTB101 Potential in Reducing Incidence of Respiratory Track Infections in Elderly Patients and Third Quarter 2018 Financial Results

Restorbio Reports Third Quarter 2018 Financial Results Nov 13, 2018 and FDA phase 2b postive news

%d bloggers like this: